Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
You mean the one about shadowy forces lurking behind the curtain teaming up and keeping the PPS down? I like everything you do here, monte—but even you must admit that this has LONG been ludicrous, and the company has gotten MORE quiet at the precise moment when they should be singing like canaries!! What gives—crap or get off the pot!
Of COURSE I agree with that—which is why I have been beating this drum for over a year!!!
You mean it’s gonna go back to somewhere like where we were over a year ago? I’m not terribly encouraged (or impressed). Smdh
Then please explain the last year + of downward spiral PPS (and using something other than “the boogey man” theory). I’ve been very committed and serious about this stock for going on two years: it’s WAY past time for some PPS-moving (in a decidedly positive direction—we’ve seen PLENTY of the opposite) RESULTS!
Thank you (as always).
While the romanticist in me loves that notion, the rationalist needs to see evidence to provide a basis to subscribe. Unlike with religion, investing is NOT an area for “faith in things unseen.”
It has ALWAYS had these...
Something somewhere is amiss—otherwise these natural catalysts would be doing their job predictably.
On paper this looks like a stock with serious long-term potential. In reality (it seems) the market utterly rejects that proposition, having annihilated shareholder value by 95+% (and thereby crippled the stock, which now has something of a stigma on it that may dissuade folks from investing in the future when they see what happened to those who did so in the past). Discuss.
The clinical trial ended on 8/28–so more like 1.5 months left (not 3)...
So where do you personally (and realistically) see the PPS in, day, 2-3 years? 5.8B OS seems like a big number—any thoughts on how the PPS rises, given that 5.8B number (which may rise even higher)?
How can the price be lower (.0001) than the current bid (.0002) and the current ask (.0003), as it was just a moment ago?
And never mind the fact that some of the patents are already generating revenue! Unreal
There’s nothing in that email that isn’t available all over the internet. Nexxxxt
A trade for ONE share?
$7 is lightyears better than .07 (or most recently .0027).
I care not about such incidental details—especially since Riordan has nothing to do with CELZ. Bottom line: Intrexon saw value enough in Medistem to pay $1+ PPS—that’s all that interests me. And btw, the company that bought them outnis trading at $7.60 PPS today, so obviously they know what they’re doing...
If I did, I wouldn’t be asking (however comfortable I may be with the rhetorical, in matters such as these I much prefer to be explicit and practical).
No—not my question. If a company with no commercialization can be bought out for $1+ PPS, how in the WORLD can one with BOTH the kind of science that Medistem had AND full commercialization be stuck under .01 (by a substantial margin) and showing ZERO signs of life? That is the logic of my question.
So why has it steadily TANKED (more than 90% since it reached .07)—at precisely the time it should be climbing, given commercialization, anticipation of reaching self-sustaining revenues during 2019, etc? And please don’t echo the chorus of those talking about “teams of MMs working to keep it down”—unless, of course, you have proof of that. Medistem, which was run by many of these same principals and was NOWHERE near commercialization, rose to $2+ per share before a buyout in the mid $1 range. HOW??
All this action since January, PPS in January was around .015, today it’s less than .0030. Makes perfect sense
So you’re saying that, in your opinion, CELZ has no prospect or purpose as “an equity,” which I define as an asset that represents real shareholder value that is backed by a real business enterprise whose efforts are squarely focused on and whose qualitative effectiveness is almost exclusively determined by the firm’s ability to increase that shareholder value (ultimately through higher PPS)?
Does the QB have explicit and higher PPS requirements than “the pinks”? That’s all most people care about—no matter what they may say. Folks are here (and in every other equity market for that matter) to make money. This equity is going definitively in the WRONG DIRECTION—despite the fact that commercialization is (and had been) in full swing for 6+ months by a CONSERVATIVE reckoning, with the company, moreover, expecting to generate revenues sufficient to sustain operations beginning in the second half of THIS YEAR. Meantime Medistem, a firm established and grown by many of the same principals as established CELZ, was NOWHERE NEAR commercialization—and yet was bought out for $1.35/share, having risen to $2+ PPS at its height. In the words of the old computer system: “Does not compute.”
So I guess losing QB status and sinking to the pinks isn’t technically “delisting,” but most would agree that (a) it would be a move in the wrong direction and (2) it would likely worsen our current trend and problems.
There are PPS requirements that must be met and maintained in order to remain on OTC.QB. My vague recollection is that it’s .01 for at least 10 sessions starting around 8/5–but someone with more time can easily confirm
In addition to what I just wrote, it appears that we a definitely headed for delisting—which will only worsen our woes.
I’m sorry, but for this to fall into the f’ing .002s is asinine and absurd. There is NO justification for ANYTHING that has ANY real value (actual or potential) to be in this range. Period. All the talk in 2018 was a pipe dream. I’m sorry to say this, but they have allowed this equity to die—at my and several others’ expense.
WHEN?! What will it take for this to show ANY signs of life???
How does 60K become $30M—I’m not understanding the math? $30M/60K=500
I see absolutely ZERO indications of this (and if it were true, we’d KNOW it now—-more than 5 of us would know it)...
+1
And it’s precisely because this is NOT a scam that this ridiculous PPS has got to END!
Breakout is a function of posting activity here within a certain timeframe, no? We’ve LONG ago learned that this board has NO effect on PPS—otherwise we’d be WELL over .50 by now...
Untrue technically: .0002 can go to quad-0. You said the game’s over. Words matter. I doubt anything is “over.”
Then someone may wanna tell Livingston Assets that they just wasted a sizable chunk of change (eyeroll)
Perhaps Livingston will perform CFO functions in exchange for roughly 10% stake? I’m kinda bummed because Garon had a solid pedigree that lended strong credibility
JG= Garon? I can find nothing that says he’s gone when I search online.
So then why did you say what you said about “money’s” apparent situation?
In principle this makes sense, but I have my doubts in this particular practical application. In the first place, a fairly recent filing showed that Dickerson and at least one other big wheel (perhaps Ichim) only 1-3M shares each. So, are they receiving salaries, while Tim takes his in stock? Are SEVERAL of them taking their salaries in stock (which would mean that CMTH is NOT Tim’s “own shares”). Just some food for thought